LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | A443654 | 1.11 | uM | LJP6 | 72 | hr | 513 | 445 | 10473 | 0.0425 | -0.0324 |
MCF 10A | Withaferin A | 1.11 | uM | LJP5 | 72 | hr | 513 | 446 | 10362 | 0.0431 | -0.0317 |
MCF 10A | AZD8330 | 0.04 | uM | LJP5 | 72 | hr | 513 | 447 | 10362 | 0.0431 | -0.0330 |
MCF 10A | Celastrol | 3.33 | uM | LJP6 | 72 | hr | 513 | 450 | 10473 | 0.0430 | -0.0312 |
MCF 10A | Alvocidib | 0.37 | uM | LJP6 | 72 | hr | 513 | 452 | 10473 | 0.0432 | -0.0298 |
MDA-MB-231 | Dasatinib | 10 | uM | LJP6 | 72 | hr | 868 | 456 | 3556 | 0.1281 | -0.2730 |
MCF 10A | Mitoxantrone | 1.11 | uM | LJP6 | 72 | hr | 513 | 458 | 10473 | 0.0438 | -0.0267 |
MCF 10A | GSK1059615 | 3.33 | uM | LJP6 | 72 | hr | 513 | 459 | 10473 | 0.0438 | -0.0260 |
MDA-MB-231 | Dasatinib | 3.33 | uM | LJP6 | 72 | hr | 868 | 460 | 3556 | 0.1292 | -0.2691 |
MCF 10A | Foretinib | 10 | uM | LJP5 | 72 | hr | 513 | 463 | 10362 | 0.0447 | -0.0245 |
MCF 10A | Mitoxantrone | 10 | uM | LJP6 | 72 | hr | 513 | 464 | 10473 | 0.0443 | -0.0231 |
MCF 10A | Luminespib | 1.11 | uM | LJP5 | 72 | hr | 513 | 465 | 10362 | 0.0449 | -0.0229 |
Hs 578T | Mitoxantrone | 10 | uM | LJP6 | 72 | hr | 929 | 466 | 3216 | 0.1450 | -0.3206 |
MCF 10A | Alvocidib | 10 | uM | LJP6 | 72 | hr | 513 | 467 | 10473 | 0.0447 | -0.0214 |
MDA-MB-231 | CGP60474 | 10 | uM | LJP6 | 72 | hr | 868 | 469 | 3556 | 0.1316 | -0.2652 |
MCF 10A | Torin2 | 0.37 | uM | LJP5 | 72 | hr | 513 | 472 | 10362 | 0.0455 | -0.0205 |
MCF 10A | Geldanamycin | 1.11 | uM | LJP6 | 72 | hr | 513 | 473 | 10473 | 0.0452 | -0.0187 |
MCF 10A | Luminespib | 0.04 | uM | LJP5 | 72 | hr | 513 | 474 | 10362 | 0.0457 | -0.0185 |
MCF 10A | Alvocidib | 1.11 | uM | LJP6 | 72 | hr | 513 | 476 | 10473 | 0.0455 | -0.0173 |
MDA-MB-231 | Withaferin A | 10 | uM | LJP5 | 72 | hr | 868 | 476 | 3410 | 0.1396 | -0.2634 |
MCF 10A | Luminespib | 0.37 | uM | LJP5 | 72 | hr | 513 | 476 | 10362 | 0.0459 | -0.0176 |
MCF 10A | AT-7519 | 10 | uM | LJP6 | 72 | hr | 513 | 482 | 10473 | 0.0461 | -0.0150 |
MCF 10A | WZ-4-145 | 10 | uM | LJP6 | 72 | hr | 513 | 483 | 10473 | 0.0461 | -0.0145 |
MCF 10A | CGP60474 | 3.33 | uM | LJP6 | 72 | hr | 513 | 484 | 10473 | 0.0462 | -0.0241 |
MCF 10A | Torin2 | 1.11 | uM | LJP5 | 72 | hr | 513 | 484 | 10362 | 0.0467 | -0.0153 |